Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BENEFYTT TECHNOLOGIES, INC.

(BFYT)
  Report
SummaryNewsRatingsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Health Insurance Innovations Inc : Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Health Insurance Innovations, Inc. of Class Action Lawsuit and Upcoming Deadline - HIIQ

09/16/2017 | 10:31am EDT

NEW YORK, NY / ACCESSWIRE / September 16, 2017 / Pomerantz LLP announces that a class action lawsuit has been filed against Health Insurance Innovations, Inc. ("Health Insurance Innovations" or the "Company") (NASDAQ: HIIQ) and certain of its officers. The class action, filed in United States District Court, Southern District of New York, and docketed under 17-cv-06962, is on behalf of a class consisting of investors who purchased or otherwise acquired Health Insurance Innovations securities, seeking to recover compensable damages caused by defendants' violations of the Securities Exchange Act of 1934.

If you are a shareholder who purchased Health Insurance Innovations securities between August 2, 2017, and September 11, 2017, both dates inclusive, you have until November 10, 2017, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

[Click here to join this class action]

Health Insurance Innovations operates as a developer, distributor, and administrator of cloud-based individual health and family insurance plans, and supplemental products in the United States. The Company offers, inter alia, short-term medical plans, hospital indemnity plans, and supplemental insurance products. It designs and structures individual health and family insurance plans, and supplemental products on behalf of insurance carriers and discount benefit providers and market them to individuals through a network of distributors.

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Health Insurance Innovations' application for a key insurance license in its home state of Florida was rejected due to the state's Office of Insurance Regulation's ("OIR") discovery of undisclosed legal actions against Health Insurance Innovations insiders; (ii) Health Insurance Innovations warned the OIR of the anticipated "domino effect" that the rejection was likely to cause, by which the Company would subsequently lose licenses in additional states; and (iii) as a result of the foregoing, Health Insurance Innovations' public statements were materially false and misleading at all relevant times.

On September 11, 2017, the website SeekingAlpha.com published an article reporting on the OIR?s June 2017 rejection of Health Insurance Innovations' application for a "key insurance license in [its] home state of Florida as [the OIR] uncovers undisclosed legal actions against HIIQ insiders" and that "HIIQ privately warns of disastrous 'domino effect' spreading to other states, causing additional loss of licenses. HIIQ makes no disclosure to investors."

On this news, Health Insurance Innovations' share price fell $6.55, or 21.91%, to close at $23.35 on September 11, 2017.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

SOURCE: Pomerantz LLP


© Accesswire 2017
All news about BENEFYTT TECHNOLOGIES, INC.
2020BENEFYTT TECHNOLOGIES, INC.  : Entry into a Material Definitive Agreement, Termi..
AQ
2020Madison Dearborn Partners Completes Acquisition of Benefytt Technologies
GL
2020BENEFYTT TECHNOLOGIES  : Sc to-t/a
PU
2020BENEFYTT TECHNOLOGIES  : Sc to-t/a
PU
2020BENEFYTT TECHNOLOGIES  : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDI..
AQ
2020SENIORS ARE EMBRACING TECHNOLOGY : From Healthcare Needs To Binge Watching
PR
2020BENEFYTT TECHNOLOGIES  : Sc to-t
PU
2020WeissLaw LLP Investigates Benefytt Technologies, Inc.
PR
2020BENEFYTT TECHNOLOGIES  : Unregistered Sale of Equity Securities (form 8-K/A)
AQ
2020STOCKHOLDER ALERT : Monteverde & Associates PC Announces an Investigation of Ben..
PR
More news
Financials (USD)
Sales 2019 382 M - -
Net income 2019 29,6 M - -
Net Debt 2019 175 M - -
P/E ratio 2019 7,81x
Yield 2019 -
Capitalization 421 M 421 M -
EV / Sales 2018 1,05x
EV / Sales 2019 1,08x
Nbr of Employees 344
Free-Float 70,0%
Income Statement Evolution
Managers and Directors
NameTitle
Gavin D. Southwell President, Chief Executive Officer & Director
Michael DeVries Chief Financial Officer
Paul G. Gabos Chairman
Paul E. Avery Director
Anthony J. Barkett Director
Sector and Competitors
1st jan.Capitalization (M$)
BENEFYTT TECHNOLOGIES, INC.60.71%421